Edgestream Partners L.P. Has $7.16 Million Stake in Ingevity Corporation $NGVT

Edgestream Partners L.P. raised its stake in shares of Ingevity Corporation (NYSE:NGVT) by 11.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,487 shares of the company’s stock after buying an additional 10,169 shares during the period. Edgestream Partners L.P. owned 0.29% of Ingevity worth $7,158,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Los Angeles Capital Management LLC raised its position in Ingevity by 94.2% in the fourth quarter. Los Angeles Capital Management LLC now owns 30,877 shares of the company’s stock worth $1,827,000 after acquiring an additional 14,975 shares during the period. Allspring Global Investments Holdings LLC bought a new position in shares of Ingevity during the 4th quarter valued at approximately $8,083,000. Pacer Advisors Inc. bought a new position in shares of Ingevity during the 4th quarter valued at approximately $9,660,000. Principal Financial Group Inc. increased its stake in shares of Ingevity by 269.9% during the 4th quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock worth $38,599,000 after purchasing an additional 475,907 shares during the last quarter. Finally, Bessemer Group Inc. increased its stake in shares of Ingevity by 465.9% during the 1st quarter. Bessemer Group Inc. now owns 314,739 shares of the company’s stock worth $22,419,000 after purchasing an additional 259,124 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on NGVT. Wall Street Zen upgraded Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research note on Friday, July 17th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $80.00.

Ingevity News Roundup

Here are the key news stories impacting Ingevity this week:

• Positive Sentiment: Quarterly earnings beat expectations. Ingevity reported second-quarter EPS of $1.74, above analyst estimates ranging from $1.31 to $1.33 and up from $1.39 a year earlier. Revenue of $314.1 million also exceeded the $312.2 million consensus estimate. Ingevity Tops Q2 Earnings and Revenue Estimates
• Positive Sentiment: Full-year 2026 adjusted EPS guidance was raised. The company now expects adjusted EPS of $5.00 to $5.45, above the prior outlook and higher than the roughly $4.95-$5.05 analyst consensus range. Ingevity also increased its full-year adjusted EBITDA outlook following a solid start to the year. Ingevity’s Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised
• Neutral Sentiment: Revenue guidance remains broadly in line with expectations. Ingevity maintained 2026 revenue guidance of approximately $1.1 billion to $1.2 billion, compared with consensus expectations near $1.1 billion. Ingevity Reports Second Quarter 2026 Financial Results
• Negative Sentiment: Net sales declined year over year. Although quarterly revenue edged past estimates, the year-over-year sales decline creates concern about underlying demand and may offset some of the benefit from stronger earnings guidance. The company also reported a negative net margin, adding to investor caution.

Insider Buying and Selling

In related news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. The trade was a 6.44% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.88% of the company’s stock.

Ingevity Price Performance

NYSE NGVT opened at $70.02 on Friday. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The company has a market cap of $2.43 billion, a PE ratio of 47.63 and a beta of 1.16. Ingevity Corporation has a 52 week low of $39.74 and a 52 week high of $79.29. The firm’s 50-day simple moving average is $71.63 and its two-hundred day simple moving average is $70.95.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 261.97%. The firm had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts predict that Ingevity Corporation will post 5.05 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.